Skip to main content

Month: June 2021

Short-term charter agreement

AS Tallink Grupp and Tanger MED Port Authority S.A., a Moroccan state-owned company, have signed short-term time-charter agreements for the vessels M/S Victoria I and M/S Romantika. The vessels will operate on international shipping routes between Morocco and France and between Morocco and Italy in July-September 2021. Joonas Joost Financial Director AS Tallink Grupp Sadama 5 10111 Tallinn, Estonia E-mail joonas.joost@tallink.ee

Continue reading

BBQ Holdings, Inc. Announces Acquisition of Village Inn and Bakers Square Restaurants and Updates Earnings Guidance for Fiscal Year 2021

MINNEAPOLIS, June 28, 2021 (GLOBE NEWSWIRE) — BBQ Holdings, Inc. (NASDAQ: BBQ) (the “Company”), an innovating global owner and operator of restaurants, provided revenue and earnings guidance in an updated investor presentation filed via Form 8-K on June 25, 2021, reflecting the announcement of the acquisition of Village Inn and Bakers Square, as well as improved operations within BBQ Holdings, Inc’s existing brands. Guidance for its fiscal year 2021 is as follows: Included in the transaction are 114 franchised Village Inn restaurants, 21 Corporate Village Inn restaurants, and 13 Corporate Bakers Square restaurants. We are increasing 2021 guidance as follows:Net Restaurant Revenue from $155-$160 mm to $180-$185 mm Net Income from $2.8-$3.2 mm to $5.1-$5.5 mm Cash EBITDA from $10.0-$10.5 mm to $13.5-$14.0 mm ($12.0-$12.5 mm from...

Continue reading

Just Energy Reports Fiscal Fourth Quarter and Full Year 2021 Results

TORONTO, June 28, 2021 (GLOBE NEWSWIRE) — Just Energy Group Inc. (“Just Energy” or the “Company”) (TSXV:JE; OTC:JENGQ), a retail energy provider specializing in electricity and natural gas commodities and bringing energy efficient solutions and renewable energy options to customers, announced its fourth quarter and year end results for fiscal year 2021 ended March 31, 2021. Recent Developments As previously released, in February 2021, the State of Texas experienced extremely cold weather (“the Weather Event”), which, combined with sustained high prices for electricity, ultimately resulted in Just Energy receiving creditor protection under the Companies’ Creditors Arrangement Act (“CCAA”) from the Ontario Superior Court of Justice (Commercial List) (the “Court”) and under Chapter 15 of the Bankruptcy Code in the United States. Protection...

Continue reading

180 Life Sciences Joins Russell Microcap® Index

MENLO PARK, Calif., June 28, 2021 (GLOBE NEWSWIRE) — 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, announced today that it has joined the Russell Microcap® Index, effective after the U.S. market opens today, June 28. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes. Dr. James Woody, 180 Life Sciences Chief Executive Officer, stated, “The Russell indexes are widely used investment benchmarks for index funds and...

Continue reading

Minera IRL Announces Updated Resources and Mine Life Extension for the Corihuarmi Gold Mine

LIMA, Peru, June 28, 2021 (GLOBE NEWSWIRE) — Minera IRL Limited (“Minera” or the “Company”) (BVL:MIRL) (CSE:MIRL), is pleased to announce the results of an updated Mineral Resource Estimate (“2021 MRE”) for its Corihuarmi Gold Mine (“Corihuarmi”) located in central Peru. The 2021 MRE, which was compiled and completed by consulting firm Mining Plus in accordance with the requirements of National Instrument 43-101 (“NI 43-101”), confirms the existence of sufficient resources to extend the life of mine (“LOM”) at Corihuarmi to August 2024, including measured and indicated resources totalling 13.8 million tonnes at an average grade of 0.21 grams per tonne (“g/t”). Diego Benavides, CEO of Minera IRL Limited, stated: “This is great news for us, as Corihuarmi – which, by the way, translates from Quechua into English as ‘the Golden Woman’...

Continue reading

Catalyst Pharmaceuticals Announces Exclusive License and Supply Agreement with DyDo Pharma for the Development and Commercialization of Firdapse® in Japan

CORAL GABLES, Fla., June 28, 2021 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing and commercializing novel high-quality medicines for patients living with rare diseases, today announced that it has entered into an exclusive license and supply agreement with DyDo Pharma, Inc. (“DyDo Pharma”) for the development and commercialization of Firdapse® (amifampridine) Tablets 10 mg in Japan for the treatment of Lambert-Eaton myasthenic syndrome (“LEMS”). LEMS is a rare autoimmune neuromuscular disorder characterized by debilitating and progressive muscle weakness and fatigue. Under the terms of the agreement, DyDo Pharma will have joint rights to develop Firdapse® (amifampridine phosphate), and exclusive...

Continue reading

ESPERION Appoints JoAnne Micale Foody, MD, FACC, FAHA as Chief Medical Officer

– Expansion of management team with proven leader in cardiovascular disease supports advancement of CLEAR Outcomes trial and ESPERION therapeutic pipeline – ANN ARBOR, Mich., June 28, 2021 (GLOBE NEWSWIRE) — ESPERION (NASDAQ: ESPR), today announced the appointment of JoAnne Micale Foody, MD, FACC, FAHA as Chief Medical Officer, effective immediately. She will serve as a member of the executive team and report to Sheldon Koenig, President and Chief Executive Officer. Dr. Foody brings more than 20 years of experience in academic and preventive cardiology to ESPERION. “Dr. Foody is a global expert with extensive clinical and medical experience in preventive cardiology, global medical development and medical affairs, which adds greatly to the depth of our management team,” said Sheldon Koenig, President and Chief Executive Officer...

Continue reading

Loncor Gold Announces Private Placement Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, June 28, 2021 (GLOBE NEWSWIRE) — Loncor Gold Inc. (“Loncor” or the “Company“) (TSX: “LN”; OTCQX: “LONCF”; FSE: “LO51”) is pleased to announce a non-brokered private placement of up to 7,000,000 units of the Company (the “Units“) at a price of Cdn$0.70 per Unit for gross proceeds of up to Cdn$4,900,000 (the “Financing“). Each Unit will consist of one common share of the Company and one-half of one common share purchase warrant (each whole common share purchase warrant, a “Warrant“) of the Company, with each Warrant entitling the holder thereof to acquire one common share of the Company at an exercise price of Cdn$0.95 for a period of 12...

Continue reading

Inovalon Announces Appointment of Eron S. Kelly as Corporate President

Seasoned Executive Focused on Global Cloud Business Growth at Amazon and Microsoft Joins Inovalon BOWIE, Md., June 28, 2021 (GLOBE NEWSWIRE) — Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced the appointment of Eron S. Kelly as its Corporate President. Mr. Kelly brings more than 20 years of experience in global software and cloud-based technology growth as a seasoned executive leader at Amazon and Microsoft. As Inovalon’s Corporate President, Mr. Kelly will be responsible for the management, operation, and results of the Company’s multiple business units, their respective growth, product offerings, value achievement, and performance, as well as related support of customer and strategic relationships, total customer experience, and industry leadership. “Eron...

Continue reading

Tempest Closes Merger with Millendo and Completes PIPE Financing

SOUTH SAN FRANCISCO, Calif., June 28, 2021 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST) (“Tempest”), a clinical-stage oncology company developing potentially first-in-class therapeutics that combine both targeted and immune-mediated mechanisms, announced today the closing of its merger with Millendo Therapeutics, Inc. (“Millendo”). Tempest’s stock will commence trading on June 28, 2021 on the Nasdaq Global Select Market under the trading symbol “TPST.” In support of the merger, Tempest secured investments from a premier syndicate of healthcare investors composed of Versant Ventures, Rock Springs Capital, F-Prime Capital, Monashee Investment Management, Quan Capital, Lyfe Capital, Maven Investment Partners US, Lilly Asia Ventures and Eight Roads Ventures for a $30 million PIPE financing that closed concurrent with...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.